Androstenetriol
From Wikipedia, the free encyclopedia
Chemical compound
Not to be confused with Androstenediol.
Pharmaceutical compound
| Clinical data | |
|---|---|
| Other names | AET; Androst-5-ene-3β,7β,17β-triol; β-Androstenetriol; β-AET |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H30O3 |
| Molar mass | 306.446 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Androstenetriol (AET, androst-5-ene-3β,7β,17β-triol, β-androstenetriol, or β-AET) is a steroid produced in the adrenal glands as a metabolite of dehydroepiandrosterone (DHEA).[1] It is believed to have similar effects as DHEA and androstenediol.[2] A study in rodents found that the compound was a weak androgen and estrogen, but did not bind to the androgen, estrogen, progesterone, or glucocorticoid receptors.[1] Synthetic analogues of androstenetriol such as bezisterim (HE3286, NE3107; the 17α-ethynylated derivative) have been developed and are under study.[3] [4] [5]
References
[edit ]- ^ a b Ahlem, Clarence N.; Auci, Dominick L.; Nicoletti, Ferdinando; Pieters, Raymond; Kennedy, Michael R.; Page, Theodore M.; Reading, Christopher L.; Enioutina, Elena Y.; Frincke, James M. (2011). "Pharmacology and immune modulating properties of 5-androstene-3β,7β,17β-triol, a DHEA metabolite in the human metabolome". The Journal of Steroid Biochemistry and Molecular Biology. 126 (3): 87–94. doi:10.1016/j.jsbmb.2011年04月01日0. ISSN 0960-0760. PMID 21570467. S2CID 5123272.
- ^ Dillon, Joseph S. (2005). "Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate and Related Steroids: Their Role in Inflammatory, Allergic and Immunological Disorders". Current Drug Targets. Inflammation and Allergy. 4 (3): 377–385. doi:10.2174/1568010054022079. PMID 16101547.
- ^ Ma, Yajing; Liu, Sufang; Zhou, Qingfeng; Li, Zhonghua; Zhang, Zhijian; Yu, Bin (2024). "Approved drugs and natural products at clinical stages for treating Alzheimer's disease" (PDF). Chinese Journal of Natural Medicines. 22 (8): 699–710. doi:10.1016/S1875-5364(24)60606-0. PMID 39197961.
Bezisterim, a derivative of the natural anti-inflammatory steroid β-AET, is an orally active NF-κB inhibitor. It has been shown to protect neurons by reducing inflammation and improving glucose utilization, thereby promoting brain health. Clinical results have demonstrated that bezisterim can improve cognition and biomarker levels in AD patients and is currently in phase III clinical trials [68].
- ^ Reading, Chris L; Ahlem, Clarence N; Parameswaran, Narayanan (December 2021). "Rationale for an anti-inflammatory insulin sensitizer in a phase 3 Alzheimer's disease trial". Alzheimer's & Dementia. 17 (S9). doi:10.1002/alz.057438 .
- ^ Reading, Christopher L.; Frincke, James M.; White, Steven K. (24 February 2012). "Molecular Targets for 17α-Ethynyl-5-Androstene-3β,7β,17β-Triol, an Anti-Inflammatory Agent Derived from the Human Metabolome". PLOS ONE. 7 (2): e32147. Bibcode:2012PLoSO...732147R. doi:10.1371/journal.pone.0032147 . ISSN 1932-6203. PMC 3286445 . PMID 22384159.
